Reviva Pharmaceuticals I...

NASDAQ: RVPH · Real-Time Price · USD
0.35
-0.41 (-54.17%)
At close: Jun 26, 2025, 3:59 PM

Reviva Pharmaceuticals Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.01 -3.12 -3.41 -5.02
PEG Ratio
0.04 -0.22 -0.02 0.09
PS Ratio
n/a n/a n/a n/a
PB Ratio
73.84 21.43 6.73 1.49
P/FCF Ratio
-1.79 -4.33 -4.37 -4.01
P/OCF Ratio
-1.79 -4.33 -4.37 -4.01
OCF/S Ratio
n/a n/a n/a n/a
Debt / Equity Ratio
0.56 n/a n/a n/a
Quick Ratio
1.01 1.38 3.13 13.39
Current Ratio
1.01 1.38 3.13 13.39
Asset Turnover
n/a n/a n/a n/a
Interest Coverage
-1.67K n/a -132.97 -4.19K
Return on Equity
-36.82 -6.87 -1.98 -0.3
Return on Assets
-1.93 -1.66 -1.29 -0.27
Return on Invested Capital
-22.67 -6.05 -1.89 -0.35
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a n/a n/a n/a
Net Profit Margin
n/a n/a n/a n/a
Pretax Profit Margin
n/a n/a n/a n/a
Operating Profit Margin
n/a n/a n/a n/a
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a n/a n/a n/a